Related Experiment Videos
Comprehensive mutational scanning of the p53 coding region by two-dimensional gene scanning
R D Rines1, N J van Orsouw, I Sigalas
1Beth Israel Deaconess Medical Center, Harvard Institute of Medicine, Boston, MA 02115, USA.
Carcinogenesis
|July 17, 1998
Summary
A new two-dimensional gene scanning (TDGS) test accurately detects p53 gene mutations using multiplex PCR and DNA electrophoresis. This cost-effective, non-radioactive method enables simultaneous scanning of all p53 coding exons.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- The p53 tumor suppressor gene is frequently mutated in human cancers.
- Accurate and efficient methods for detecting p53 mutations are crucial for cancer diagnosis and research.
- Existing mutation detection methods can be time-consuming, costly, or involve radioactivity.
Purpose of the Study:
- To develop and evaluate a novel, comprehensive mutational scanning test for the p53 coding region.
- To establish a cost-effective, non-radioactive, and accurate method for simultaneous detection of p53 mutations.
- To validate the assay using DNA samples from Li-Fraumeni syndrome patients.
Main Methods:
- A two-step multiplex PCR approach was employed to amplify the entire p53 coding region (exons 2-11) as a single large fragment.
- Long-distance PCR was used for initial amplification, followed by co-amplification of individual exons in two multiplex groups.
- Two-dimensional DNA electrophoresis, combining size separation on non-denaturing polyacrylamide gels and sequence separation by denaturing gradient gel electrophoresis (DGGE), was utilized.
Main Results:
- The developed two-dimensional gene scanning (TDGS) test successfully detected all known germline mutations in a blinded study of 29 Li-Fraumeni syndrome patient DNA samples.
- The assay demonstrated high accuracy in identifying mutations across all p53 coding exons.
- Primer design was optimized using a computer program for improved PCR, melting behavior, and 2-D gel distribution.
Conclusions:
- The two-dimensional gene scanning (TDGS) test is a highly accurate and efficient method for comprehensive mutational scanning of the p53 gene.
- This assay offers a cost-effective and non-radioactive alternative for simultaneous detection of mutations in all p53 coding exons.
- The TDGS test has significant potential for clinical diagnostics and research involving p53-related genetic disorders and cancers.